Alpha 2.0
Login Register
» Authors » U Amon

U Amon

Explore the profile of U Amon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 153
Followers 0
Related Specialties
Dermatology
Allergy & Immunology
Pharmacology
Top 10 Co-Authors
H H Wolff
B F Gibbs
E von Stebut
M Nitschke
D DIECKMANN
T Noll
M Augustin
S Amon
H Haas
I B Vollrath
Published In
Inflamm Res
Hautarzt
Agents Actions
J Eur Acad Dermatol Venereol
Arch Dermatol Res
Affiliations
Soon will be listed here.
Recent Articles
1.
Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and safety from the PROSPECT study
Thaci D, Korber A, von Kiedrowski R, Bachhuber T, Melzer N, Kasparek T, et al.
J Eur Acad Dermatol Venereol . 2019 Sep; 34(2):310-318. PMID: 31541554
Background: Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, has demonstrated efficacy and safety in patients with moderate-to-severe psoriasis. Trial protocols specify transition periods and prohibit concomitant psoriasis medication. Data are...
2.
Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study
Korber A, Thaci D, von Kiedrowski R, Bachhuber T, Melzer N, Kasparek T, et al.
J Eur Acad Dermatol Venereol . 2017 Sep; 32(3):411-419. PMID: 28960469
Background: Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, has demonstrated efficacy and safety in patients with moderate to severe psoriasis. However, as per study protocols, transition periods from prior psoriasis...
3.
Spontaneous histamine release from mast cells and basophils is controlled by the cellular environment
Gibbs B, Amon U, Pearce F
Inflamm Res . 2016 Aug; 46(Suppl 1):25-6. PMID: 27517986
No abstract available.
4.
[Treatment of granulomatous cheilitis with fumaric acid esters in a young woman]
Kleine R, Brohl L, Amon U
Hautarzt . 2011 Apr; 62(12):940-2. PMID: 21523519
Granulomatous cheilitis is a rare granulomatous inflammation of the lips of unknown origin; mainly young adults are affected. So far, there is no generally effectual treatment available for this disfiguring...
5.
[Recommendations for quality management in dermatologic clinics and dermatologist practices]
Amon U, Buhles N, Winker B, Schulze P, Seidel C, Weidenbach T
J Dtsch Dermatol Ges . 2005 Nov; 1(10):816-35. PMID: 16281819
No abstract available.
6.
Comparison of severity scoring of atopic dermatitis values and serum levels of eosinophil cationic protein and mast cell tryptase for routine evaluation of atopic dermatitis
Amon U, Memmel U, Stoll R, Amon S
Acta Derm Venereol . 2000 Oct; 80(4):284-6. PMID: 11028863
In this study the routine use of different parameters for evaluation of the overall therapeutic outcome in atopic dermatitis was investigated. The disease activity of 117 randomly selected hospitalized patients...
7.
In vitro studies with fexofenadine, a new nonsedating histamine H1 receptor antagonist, on isolated human basophils
Amon U, Amon S, Gibbs B
Inflamm Res . 2000 Jun; 49 Suppl 1:S13-4. PMID: 10864400
No abstract available.
8.
In vitro investigations with the histamine H1 receptor antagonist, epinastine (WAL 801 CL), on isolated human allergic effector cells
Amon U, Gibbs B, Buss G, Nitschke M
Inflamm Res . 2000 May; 49(3):112-6. PMID: 10807498
Objective And Design: Skin mast cells, basophils and eosinophils are effector cells of acute and subacute allergic responses due to their capacity to produce a large number of (pro)inflammatory mediators....
9.
[The "Hersbruck Model". Application and integration of the DIN EN ISO 9001 quality norms with criteria of the European Foundation for Quality Management in a clinic]
Fritze B, Amon U
Z Arztl Fortbild Qualitatssich . 2000 Feb; 93(9):701-7. PMID: 10666835
The german health system has dramatically changed and still continues to do so. Modified aspects concerning economy, customer orientation, competition, quality assurance and quality management seem to be increasingly important....
10.
[Effects of combined dermatological and behavioural medicine therapy in hospitalized patients with psoriasis and atopic dermatitis]
Lange S, Zschocke I, Langhardt S, Amon U, Augustin M
Hautarzt . 1999 Dec; 50(11):791-7. PMID: 10591789
The present study examined the effectiveness of combined dermatological and behavioural medicine therapy on the skin status and disease-specific stress of eighty-six patients with psoriasis and fifty-eight patients with atopic...